| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President & CEO
1 company
Jason Patrick Meyenburg last filed a Form 4 in January 2022, as President & CEO at IRON. Jason Patrick Meyenburg's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 13,000 shares of IRON. Net of sales, the IRON filings show accumulation of 13,000 shares.
Jason Patrick Meyenburg has 3 Form 4 filings on record from February 2021 to January 2022, all as Chief Executive Officer at Disc Medicine (IRON), 2021–2022.
The 3 reported transactions were 2 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $123K and no sales.
The only open-market purchase was 13,000 shares of IRON at an average $9.46 on May 14, 2021, about $123K. Twelve months later IRON was down 85%.
Shares as reported in the last Form 4 for each company; the most recent is from January 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2021 | IRON Disc Medicine, Inc. | President & CEO | Buy | 13,000 | $9.46 | $122,929.30 | New | -56.8% | -85.3% |